Q1 2021 U.S. Research Perspective

Despite a recent slowdown due to the temporary suspension of the use of the Johnson & Johnson one-dose vaccine, the U.S. continues to make strong progress overall in the vaccine rollout. 

In aggregate, more than 225 million doses have been given and more than half of the U.S. adult population has now received at least one shot.  Reflecting this, COVID-related restrictions are largely being eased in most states, school systems are rapidly returning to in-person learning and office tenants that were forced to curtail using their space are beginning the conversation of when and how their employees will return.   

You can now read the full research report at the link below